Oral cancer screening: what have we learnt and what is there still to achieve?

Author： Brocklehurst Paul R Baker Sarah R M Speight Paul

ISSN： 1479-6694

Source： Future Oncology, Vol.6, Iss.2, 2010-02, pp. : 299-304

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

What have we learnt from previous phase II trials to help in the management of childhood brain tumours?

By Chastagner P. Bouffet E. Grill J. Kalifa C.

European Journal of Cancer, Vol. 37, Iss. 16, 2001-11 ,pp. : 1981-1993

Elsevier

Access to resources Recommend Favorite

Dendritic cell-based therapeutic cancer vaccines: what we have and what we need

By Kalinski Pawel Urban Julie Narang Rahul Berk Erik Wieckowski Ewa Muthuswamy Ravikumar

Future Oncology, Vol. 5, Iss. 3, 2009-04 ,pp. : 379-390

Future Medicine

Access to resources Recommend Favorite

Ionising radiation and cancer risks: What have we learned from epidemiology?

By Gilbert Ethel

International Journal of Radiation Biology, Vol. 85, Iss. 6, 2009-06 ,pp. : 467-482

Informa Healthcare

Access to resources Recommend Favorite

Multi-Targeted Agents in Cancer Cell Chemosensitization: What We Learnt from Curcumin Thus Far

Recent Patents on Anti-Cancer Drug Discovery, Vol. 11, Iss. 1, 2016-02 ,pp. : 67-97

Bentham Science Publishers

Access to resources Recommend Favorite

Mammographic Screening for Breast Cancer. What Cancers Do We Find?

By Norden T. Thurfjell E. Hasselgren M. Lindgren A. Norgren A. Bergstrom R. Holmberg L.

European Journal of Cancer, Vol. 33, Iss. 4, 1997-04 ,pp. : 624-628

Elsevier

Access to resources Recommend Favorite